Insider Trading activities of Trevena Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Trevena Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Trevena Inc since year 2005. Table 2 shows the detailed insider transactions of Trevena Inc since 2005. The reporting company's ticker symbol is TRVN. The reporting company's CIK number is 1429560.
The total value of stock buying since 2005 is $21,684,859.
The total value of stock sales since 2005 is $544,011.
The total value of stock option exercises since 2005 is $160,187.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Trevena Inc (TRVN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-02 0 $0 0 $0 110,403 $75,294
2016-11 21,500 $89,209 0 $0 0 $0
2016-05 22,084 $157,274 0 $0 0 $0
2015-12 0 $0 27,217 $287,139 0 $0
2014-12 1,609,500 $6,438,398 0 $0 0 $0
2014-09 0 $0 44 $308 0 $0
2014-08 0 $0 42,402 $256,564 0 $0
2014-04 0 $0 0 $0 124,477 $84,893
2014-02 2,142,854 $14,999,978 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Trevena Inc insiders (TRVN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-02-23 Gowen Maxine (President & CEO) Option Ex 110,403 .68 75,294
2016-11-09 Bourdow Carrie L. (SVP, Chief Commercial Officer) Buy 4,000 4.34 17,360
2016-11-07 Habib Yacoub (SVP, Bus Dev & Corp Planning) Buy 5,000 4.12 20,600
2016-11-07 Gowen Maxine (President & CEO) Buy 12,500 4.10 51,249
2016-05-27 Gowen Maxine (President & CEO) Buy 14,084 7.08 99,714
2016-05-26 Gowen Maxine (President & CEO) Buy 8,000 7.20 57,560
2015-12-10 Soergel David (Sr. VP,Clinical Dev. & CMO) Sale 27,217 10.55 287,139
2014-12-12 Limongelli John M (Sr. VP,General Counsel & Secy) Buy 3,000 4.14 12,419
2014-12-10 Yanni Barbara (Director) Buy 1,250 4.00 5,000
2014-12-10 Lark Michael W. (Sr. VP, Research & CSO) Buy 5,000 4.00 20,000
2014-12-10 Soergel David (Sr. VP, Clinical Development) Buy 1,250 4.00 5,000
2014-12-10 Cuca Roberto (Sr. VP and CFO) Buy 25,000 4.00 100,000
2014-12-10 Limongelli John M (Sr. VP,General Counsel & Secy) Buy 9,000 4.00 36,000
2014-12-10 Gowen Maxine (President & CEO) Buy 8,000 4.00 32,000
2014-12-10 Sandell Scott D (10% Owner) Buy 1,000,000 4.00 4,000,000
2014-12-10 Moulder Leon O Jr (Director) Buy 19,800 4.06 80,387
2014-12-10 Nohra Guy P (10% Owner) Buy 500,000 4.00 2,000,000
2014-12-10 Dougherty Michael R (Director) Buy 7,000 4.00 28,000
2014-12-09 Moulder Leon O Jr (Director) Buy 30,200 3.96 119,592
2014-09-29 Deegan Rosamond (Sr VP, Bus Dev & Operations) Sale 44 7.00 308
2014-08-14 Flint Jonathan A (10% Owner) Sale 36,702 6.04 221,680
2014-08-13 Flint Jonathan A (10% Owner) Sale 5,700 6.12 34,884
2014-04-23 Gowen Maxine (President & CEO) Option Ex 124,477 .68 84,893
2014-02-05 Fli International, Llc (10% Owner) Buy 428,571 7.00 2,999,997
2014-02-05 Polaris Venture Partners V, L.p. (10% Owner) Buy 472,405 7.00 3,306,835
2014-02-05 Sandell Scott D (10% Owner) Buy 472,410 7.00 3,306,870
2014-02-05 Nohra Guy P (10% Owner) Buy 472,410 7.00 3,306,870
2014-02-05 Werner Harold R (10% Owner) Buy 297,058 7.00 2,079,406

Insider trading activities including stock purchases, stock sales, and option exercises of TRVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Trevena Inc (symbol TRVN, CIK number 1429560) see the Securities and Exchange Commission (SEC) website.